Tuesday, June 1, 2021

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug

Eli Lilly gets DCGI emergency use approval for COVID-19 antibody cocktail drug Lilly said it is engaged in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with COVID-19.

from Moneycontrol Business News https://ift.tt/3p6Q9cZ
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...